Ziad Mallat Selected Research

Interleukin-10 (Interleukin 10)

12/2023	Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells.
1/2019	Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.
7/2017	The Dendritic Cell Receptor DNGR-1 Promotes the Development of Atherosclerosis in Mice.
9/2015	Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.
8/2015	Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice.
1/2014	Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
10/2013	Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice.
9/2009	Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis.
4/2006	Cytokines in atherosclerosis: pathogenic and regulatory pathways.
3/2006	In vivo electrotransfer of interleukin-10 cDNA prevents endothelial upregulation of activated NF-kappaB and adhesion molecules following an atherogenic diet.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziad Mallat Research Topics

Disease

94	Atherosclerosis 01/2024 - 05/2002
37	Inflammation (Inflammations) 02/2024 - 10/2003
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2007
16	Atherosclerotic Plaque (Atheroma) 01/2021 - 10/2002
15	Myocardial Infarction 11/2021 - 10/2005
14	Rupture 11/2022 - 03/2003
11	Aneurysm (Aneurysms) 01/2022 - 02/2010
11	Abdominal Aortic Aneurysm 01/2021 - 06/2011
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 10/2005
8	Acute Coronary Syndrome 10/2022 - 10/2005
6	Thrombosis (Thrombus) 01/2019 - 03/2003
5	Autoimmune Diseases (Autoimmune Disease) 12/2023 - 10/2010
5	Infarction (Infarctions) 01/2021 - 03/2013
5	Heart Failure 12/2020 - 11/2004
5	Coronary Disease (Coronary Heart Disease) 11/2018 - 11/2009
4	Aortic Dissection 11/2022 - 01/2016
4	Infections 11/2019 - 10/2007
4	Aortic Rupture 01/2019 - 12/2011
4	Aortic Aneurysm (Aneurysm, Aortic) 01/2019 - 02/2010
4	Ischemia 10/2009 - 09/2002
3	Heart Diseases (Heart Disease) 10/2022 - 10/2007
3	Disease Progression 01/2022 - 09/2015
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 11/2004
3	Neoplasms (Cancer) 01/2022 - 12/2014
3	Hypercholesterolemia 07/2017 - 04/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 06/2002
3	Stroke (Strokes) 09/2011 - 02/2006
2	Endotoxemia 11/2023 - 01/2018
2	Non-ST Elevated Myocardial Infarction 10/2022 - 12/2012
2	ST Elevation Myocardial Infarction 10/2022 - 01/2022
2	Unstable Angina 10/2022 - 02/2012
2	Ischemic Stroke 11/2021 - 10/2018
2	Ventricular Remodeling 01/2021 - 01/2018
2	Necrosis 12/2020 - 10/2018
2	Obesity 10/2018 - 01/2018
2	Hypertension (High Blood Pressure) 10/2018 - 01/2017
2	Insulin Resistance 01/2018 - 01/2009
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2015
2	Reperfusion Injury 01/2018 - 11/2004

Drug/Important Bio-Agent (IBA)

18	Apolipoproteins E (ApoE)IBA 01/2023 - 02/2003
17	Secretory Phospholipases A2IBA 11/2021 - 10/2005
15	CholesterolIBA 01/2022 - 05/2002
15	CytokinesIBA 12/2020 - 10/2002
13	LDL Receptors (LDL Receptor)IBA 01/2021 - 08/2004
12	ApolipoproteinsIBA 01/2020 - 09/2003
11	Interleukin-10 (Interleukin 10)IBA 12/2023 - 08/2004
10	Angiotensin IIIBA 01/2022 - 02/2010
10	CollagenIBA 07/2017 - 10/2002
9	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2006
9	LipidsIBA 01/2023 - 02/2006
9	Lipoproteins (Lipoprotein)IBA 01/2019 - 10/2010
8	AntibodiesIBA 01/2024 - 06/2011
8	EnzymesIBA 03/2019 - 02/2012
8	Phospholipases (Phospholipase)IBA 10/2015 - 11/2010
7	InterleukinsIBA 12/2020 - 08/2008
7	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 10/2002
7	oxidized low density lipoproteinIBA 01/2017 - 04/2007
7	Interleukin-17 (Interleukin 17)IBA 02/2015 - 09/2009
5	C-Reactive ProteinIBA 10/2022 - 08/2008
5	Interleukin-2 (IL2)IBA 10/2022 - 01/2018
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 09/2002
5	LigandsIBA 12/2020 - 12/2002
5	Immunoglobulin M (IgM)IBA 01/2019 - 10/2011
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2014 - 09/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 12/2013 - 10/2002
4	Interleukin-18 (Interleukin 18)IBA 01/2024 - 09/2002
4	Phosphotransferases (Kinase)IBA 11/2023 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2004
4	AntigensIBA 11/2019 - 02/2006
4	InflammasomesIBA 01/2019 - 04/2014
4	Peptides (Polypeptides)IBA 12/2016 - 06/2002
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 12/2012
3	Interleukin-33IBA 12/2020 - 10/2018
3	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2014
3	Pancreatic Elastase (Elastase)IBA 01/2019 - 09/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2015
3	Immunoglobulin G (IgG)IBA 01/2019 - 10/2011
3	Metalloproteases (Metalloproteinases)IBA 01/2018 - 08/2008
3	Monoclonal AntibodiesIBA 11/2017 - 08/2010
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2016 - 08/2008
3	Messenger RNA (mRNA)IBA 04/2014 - 11/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2013 - 10/2002
3	ChemokinesIBA 05/2011 - 01/2005
2	aldesleukin (Proleukin)FDA Link 01/2022 - 01/2018
2	KynurenineIBA 01/2021 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 12/2012
2	EpitopesIBA 01/2019 - 12/2007
2	B-Cell Activating FactorIBA 11/2018 - 07/2012
2	B-Cell Activation Factor ReceptorIBA 11/2018 - 07/2012
2	Troponin T (Troponin T1)IBA 01/2018 - 09/2011
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2018
2	Interleukin-22 (IL-22)IBA 01/2018 - 01/2018
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018 - 09/2015
2	Tissue Inhibitor of Metalloproteinase-1IBA 09/2017 - 08/2008
2	Immunoglobulin E (IgE)IBA 07/2017 - 01/2017

Therapy/Procedure

13	Therapeutics 01/2022 - 12/2003
4	Ligation 01/2018 - 12/2003
3	Immunomodulation 01/2020 - 09/2004
3	Immunotherapy 11/2018 - 01/2016
2	Injections 01/2020 - 03/2013